When will the FDA approve Compass Pathways' COMP360 Psilocybin?
COMP360 Psilocybin for Treatment-Resistant DepressionScience
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
COMP360 Psilocybin for Treatment-Resistant DepressionScience
Kalshi Active 5 markets·88¢ When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?·$0 Total Volume·-- Liquidity·-- OI
6mo·Jan 8, 2027
Track your prediction positions
Connect your Kalshi account to track your contracts, P&L, and settlements.
Wide spread
No chart data available
Markets
5For Treatment-Resistant Depression
$0 vol
For Treatment-Resistant Depression
$0 vol
For Treatment-Resistant Depression
$0 vol
For Treatment-Resistant Depression before Mar 2027
$0 vol
For Treatment-Resistant Depression before Jan 2027
$0 vol
For Treatment-Resistant Depression
No order book data available
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
Track Your Bets on Kalshi — and Everything Else
Create a free portfolio starting with your Kalshi positions, P&L & live odds. Then add crypto wallets, exchanges, DeFi & more — all in one place.
Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% free· Read-only· Encrypted